Monocytic Myeloid-Derived Suppressor Cells Underpin Resistance to Adoptive T Cell Therapy in Nasopharyngeal Carcinoma-Reference-Cited by-同舟云学术

Monocytic Myeloid-Derived Suppressor Cells Underpin Resistance to Adoptive T Cell Therapy in Nasopharyngeal Carcinoma

Published:2021-02 Issue:2 Volume:29 Page:734-743
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Hopkins Richard,Xiang Wenwei,Marlier Damien,Au Veonice Bijin,Ching Qianting,Wu Lynn Xue,Guan Rujun,Lee Bernett,Chia Whay-Kuang,Wang Who-Whong,Wee Joseph,Ng Joanna,Cheong Rachael,Han Shuting,Chu Axel,Chee Chit Lai,Shuen Timothy,Podinger Michael,Lezhava Alexander,Toh Han Chong,Connolly John E.

Funder

National Medical Research Council

Agency for Science, Technology and Research

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference73 articles.

1. The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: a need for reappraisal;Chang;Virus Res.,2009

2. Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety;Wee;J. Clin. Oncol.,2005

3. A phase II study evaluating the safety and efficacy of an adenovirus-ΔLMP1-LMP2 transduced dendritic cell vaccine in patients with advanced metastatic nasopharyngeal carcinoma;Chia;Ann. Oncol.,2012

4. Nucleofection of DCs to generate Multivirus-specific T cells for prevention or treatment of viral infections in the immunocompromised host;Gerdemann;Mol. Ther.,2009

5. Stroma-mediated dysregulation of myelopoiesis in mice lacking I κ B α;Rupec;Immunity,2005

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gemcitabine, carboplatin, and Epstein Barr virus-specific autologous cytotoxic T lymphocytes for recurrent or metastatic nasopharyngeal carcinoma: VANCE, an international randomized Phase 3 trial;Annals of Oncology;2024-09

2. Single-cell resolution profiling of the immune microenvironment in primary and metastatic nasopharyngeal carcinoma;Journal of Cancer Research and Clinical Oncology;2024-08-19

3. Role of long non-coding RNA in chemoradiotherapy resistance of nasopharyngeal carcinoma;Frontiers in Oncology;2024-02-29

4. Nasopharyngeal carcinoma: current views on the tumor microenvironment's impact on drug resistance and clinical outcomes;Molecular Cancer;2024-01-22

5. Update on Radiotherapy Changes of Nasopharyngeal Carcinoma Tumor Microenvironment;World Journal of Oncology;2023-10